Long-term administration of norethindrone in fertility control.
Rice-wray
E
E
Schulz-contreras
M
M
Guerrero
I
I
Aranda-rosell
A
A
D002489:Central America; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003710:Demography; D004717:Endometrium; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007843:Latin America; D008800:Mexico; D009640:Norethindrone; D010298:Parity; D010342:Patient Acceptance of Health Care; D010352:Patient Dropouts; D011153:Population; D011157:Population Dynamics; D011203:Poverty; D012106:Research; D012725:Sexual Behavior; D013995:Time; D013997:Time Factors
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D009640:Norethindrone
Acceptor Characteristics; Central America; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods--side effects; Contraceptive Usage; Demographic Factors; Dropouts; Endometrial Effects; Evaluation; Family Planning; Latin America; Longterm Effects; Low Income Population; Method Acceptability; Mexico; Norethindrone--administraction and dosage; Norethindrone--side effects; Oral Contraceptives--side effects; Parity; Population; Population Dynamics; Research Methodology; Reversibility; Sex Behavior; Time Factors; Use-effectiveness